Temozolomide and haemoglobin decreased Patient Reports February 11, 2012
Temozolomide Side Effects Report #5612274-X
Temozolomide side effect was reported by a Physician from MEXICO on Jan 22, 2008. Female patient, 67 years of age, weighting 114.6 lb, was diagnosed with neoplasm malignant and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: abdominal pain
, acidosis, asthenia, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, hepatic encephalopathy, leukopenia, nausea
. Temozolomide dosage: 215 MG;QD. During the same period patient was treated with LOMOTIL. Patient was hospitalized. Patient died on 01/23/2008.Temozolomide Side Effects Report #5179662-X
Temozolomide side effect was reported by a Physician from NETHERLANDS on Nov 29, 2006. Male patient, 70 years of age, weighting 231.5 lb, was diagnosed with metastatic malignant melanoma and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: haematemesis, haematocrit decreased, haemoglobin decreased, mallory-weiss syndrome, platelet count decreased, vomiting. Temozolomide dosage: unknown. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5774589-4
Temozolomide side effect was reported by a Physician from UNITED STATES on June 06, 2008. Female patient, 66 years of age, weighting 139.0 lb, was diagnosed with leiomyosarcoma and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, idiopathic thrombocytopenic purpura, subarachnoid haemorrhage, treatment failure. Temozolomide dosage: 140 MG;QD;PO. During the same period patient was treated with ATIVAN, CRESTOR, METOPROLOL TARTRATE, NEURONTIN, PRILOSEC, ZOFRAN, ASPIRIN, CALCIUM. Patient was hospitalized. Patient died on 05/25/2008.
Temozolomide Side Effects Report #5801985-9
Temozolomide side effect was reported by a Physician from UNITED STATES on June 27, 2008. Female patient, 66 years of age, weighting 139.0 lb, was diagnosed with leiomyosarcoma and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: autoimmune thrombocytopenia, haematoma, haemoglobin decreased, haemorrhage intracranial, oral disorder, petechiae, subarachnoid haemorrhage. Temozolomide dosage: 140 MG; QD; PO. During the same period patient was treated with ATIVAN, CRESTOR, METOPROLOL, NEURONTIN, PRILOSEC, ZOFRAN, ASPIRIN, CALCIUM. Patient was hospitalized. Patient died on 05/25/2008.
Temozolomide Side Effects Report #5701690-3
Temozolomide side effect was reported by a Physician from UNITED STATES on Mar 28, 2008. Male patient, 88 years of age, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: cryptogenic organising pneumonia, haemoglobin decreased, hypoxia, neutrophil count increased, pulmonary toxicity, white blood cell count decreased. Temozolomide dosage: 75 MG/M2; QD; 200 MG;/M2; QM. During the same period patient was treated with ATENOLOL, NIFEDIPINE, SIMVASTATIN, LEVOTHYROXINE, HYDROCHLOROTHIAZIDE, DEXAMETHASONE. Patient recovered.
Temozolomide Side Effects Report #6002193-1
Temozolomide side effect was reported by a Physician from UNITED STATES on Dec 04, 2008. Male patient, 75 years of age, weighting 196.2 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: febrile neutropenia, haematocrit decreased, haemoglobin decreased, wheezing, white blood cell count decreased. Temozolomide dosage: 430 MG; QD; PO. During the same period patient was treated with BEVACIZUMAB, CARDIZEM CD, COZAAR, ALLEGRA, FLONASE, FLOVENT, KEPPRA. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5242592-9
Temozolomide side effect was reported by a Physician from UNITED STATES on Feb 07, 2007. Female patient, 74 years of age, weighting 135.1 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: anorexia, atelectasis, cognitive disorder, disease progression, dysphagia, haemoglobin decreased, hemiparesis, herpes zoster. Temozolomide dosage: 125 MG;QD; PO. During the same period patient was treated with RADIATION, ZIAC, PROTONIX, AVANDIA, PRANDIN, PHENYTOIN, BACTRIM, XOPONEX. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5257049-9
Temozolomide side effect was reported by a Physician from UNITED STATES on Feb 26, 2007. Female patient, 74 years of age, weighting 135.1 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: anorexia, aphagia, atelectasis, cognitive disorder, disease progression, haemoglobin decreased, hemiparesis, herpes zoster. Temozolomide dosage: 125 MG;QD;PO. During the same period patient was treated with RADIATION, ZIAC, PROTONIX, AVANDIA, PRANDIN, PHENYTOIN, BACTRIM, XOPENEX. Patient was hospitalized. Patient died on 02/12/2007.
Temozolomide Side Effects Report #5366196-2
Temozolomide side effect was reported by a Physician from UNITED STATES on June 14, 2007. Female patient, 73 years of age, weighting 152.1 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: aspartate aminotransferase abnormal, blood alkaline phosphatase abnormal, fatigue, haemoglobin decreased, hyperbilirubinaemia, hypoalbuminaemia, hypotension, infection
, lung infiltration. Temozolomide dosage: 75 MG/M2; QD; PO. During the same period patient was treated with COUMADIN, DECADRON, KEPPRA, PEPCID, ZOCOR. Patient was hospitalized. Patient died on 05/15/2007.Temozolomide Side Effects Report #5822322-X
Temozolomide side effect was reported by a Health Professional from SAUDI ARABIA on July 16, 2008. Female patient, 68 years of age, weighting 147.7 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: fatigue, granulocyte count decreased, haemoglobin decreased, hypokalaemia, lymphopenia, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Temozolomide dosage: 130 MG. Patient recovered.
Temozolomide Side Effects Report #5831847-2
Temozolomide side effect was reported by a Physician from ISRAEL on July 20, 2008. Female patient, 68 years of age, weighting 147.7 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: fatigue, haemoglobin decreased, hypokalaemia, lymphopenia, neutrophil count decreased, oropharyngeal pain, platelet count decreased, pyrexia, white blood cell count decreased. Temozolomide dosage: 130 MG;. Patient recovered.
Temozolomide Side Effects Report #5835128-2
Temozolomide side effect was reported by a Physician from ISRAEL on July 29, 2008. Female patient, 68 years of age, weighting 147.7 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, lymphopenia, oropharyngeal pain, pyrexia. Temozolomide dosage: 130 MG. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5322654-8
Temozolomide side effect was reported by a Physician from UNITED STATES on Apr 27, 2007. Female patient, 67 years of age, weighting 146.2 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: cognitive disorder, convulsion, haemoglobin decreased, lung infiltration, muscle twitching, platelet count decreased, pneumonia
, pulmonary embolism
. Temozolomide dosage: 75 MG/M2;QD;PO. Patient was hospitalized. Patient recovered.Temozolomide Side Effects Report #5333133-6
Temozolomide side effect was reported by a Physician from UNITED STATES on May 15, 2007. Female patient, 67 years of age, weighting 183.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: dehydration, fatigue, haemoglobin decreased, hyperbilirubinaemia, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Temozolomide dosage: 145 MG; QD; PO. During the same period patient was treated with ACTOS, DARVOCET, GEMFIBROZIL, GLIPIZIDE, HYZAAR, LIPITOR, METOPROLOL SUCCINATE, POTASSIUM ACETATE. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5336324-3
Temozolomide side effect was reported by a Physician from UNITED STATES on May 15, 2007. Female patient, 67 years of age, weighting 183.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: dehydration, haemoglobin decreased, hyperbilirubinaemia, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Temozolomide dosage: 145 MG;QD;PO. During the same period patient was treated with ACTOS, DARVOCET, GEMFIBROZIL, GLIPIZIDE, HYZAAR, LIPITOR, METOPROLOL SUCCINATE, POTASSIUM ACETATE. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5336629-6
Temozolomide side effect was reported by a Physician from UNITED STATES on May 21, 2007. Female patient, 67 years of age, weighting 183.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: anorexia, aplastic anaemia, dehydration, fatigue, haemoglobin decreased, hyperbilirubinaemia, hypoalbuminaemia, hypokalaemia, muscular weakness. Temozolomide dosage: 145 MG; QD; PO. During the same period patient was treated with ACTOS, DARVOCET, GEMFIBROZIL, GLIPIZIDE, HYZAAR, LIPITOR, METOPROLOL SUCCINATE, POTASSIUM ACETATE. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5463844-3
Temozolomide side effect was reported by a Physician from UNITED STATES on Sept 12, 2007. Female patient, 67 years of age, weighting 146.2 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: cognitive disorder, convulsion, haemoglobin decreased, muscle twitching, platelet count decreased, pneumonia
, pulmonary embolism
, white blood cell count decreased. Temozolomide dosage: 75 MG/M2; QD;PO. Patient was hospitalized. Patient recovered.Temozolomide Side Effects Report #5746157-1
Temozolomide side effect was reported by a Physician from ISRAEL on May 11, 2008. Male patient, 67 years of age, weighting 122.4 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: asthenia, balance disorder, blood cholesterol increased, blood glucose increased, blood phosphorus decreased, fall
, haematocrit increased, haemoglobin decreased, laboratory test abnormal. Temozolomide dosage: 130 MG; QD; PO. During the same period patient was treated with AUGMENTIN, DEXAMETHASONE, HEPARIN. Patient was hospitalized. Patient recovered.Temozolomide Side Effects Report #5062935-9
Temozolomide side effect was reported by a Physician from SWITZERLAND on July 14, 2006. Male patient, 55 years of age, weighting 160.9 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: asthenia, central nervous system abscess, dyspnoea, haemoglobin decreased, headache
, herpes virus infection, immunosuppression, kaposi's sarcoma
. Temozolomide dosage: 180 MG QD* ORAL. During the same period patient was treated with TEMOZOLOMIDE CAPSULES, TEMOZOLOMIDE CAPSULES, TEMOZOLOMIDE CAPSULES, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Temozolomide Side Effects Report #5603655-9
Temozolomide side effect was reported by a Physician from UNITED STATES on Jan 11, 2008. Female patient, 40 years of age, weighting 187.8 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: anorexia, asthenia, chills, diarrhoea, dysphagia, gastric stenosis, haemoglobin decreased, ill-defined disorder, international normalised ratio increased. Temozolomide dosage: 75 MG/M2; QD; PO, 75 MG/M2; QD; PO. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5746294-1
Temozolomide side effect was reported by a Physician from ISRAEL on May 11, 2008. Male patient, weighting 196.2 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: atrial fibrillation
, blood glucose increased, haematocrit decreased, haemoglobin decreased, loss of consciousness, lymphocyte count decreased, neutrophil percentage increased, pallor, procedural complication. Temozolomide dosage: 160 MG; QD;. During the same period patient was treated with AMLODIPINE, ENALAPRIL MALEATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Temozolomide Side Effects Report #5758137-0
Temozolomide side effect was reported by a Physician from ISRAEL on May 20, 2008. Male patient, weighting 196.2 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: atrial fibrillation
, blood glucose increased, haematocrit decreased, haemoglobin decreased, loss of consciousness, lymphocyte count decreased, neutrophil percentage increased, pallor, red blood cell count decreased. Temozolomide dosage: 160 MG; QD;. During the same period patient was treated with AMLODIPINE, ENALAPRIL MALEATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.Temozolomide Side Effects Report #4711712-4
Temozolomide side effect was reported by a Consumer or non-health professional from UNITED STATES on July 08, 2005. Female patient, weighting 113.2 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, neutropenia, red blood cell count decreased, white blood cell count decreased. Temozolomide dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient recovered.
Temozolomide Side Effects Report #4773005-9
Temozolomide side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 16, 2005. Male patient, weighting 183.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: abdominal pain
, asthenia, diarrhoea, fatigue, haemoglobin decreased, laboratory test abnormal, lethargy, lymphopenia, malaise. Temozolomide dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.Temozolomide Side Effects Report #5731149-9
Temozolomide side effect was reported by a Physician from GERMANY on Apr 30, 2008. Male patient, 68 years of age, weighting 147.7 lb, was diagnosed with glioblastoma, pain
, cardiac failure, oedema peripheral, atrial fibrillation
and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: blood pressure increased, cardiac disorder, dyspnoea, haemoglobin decreased, pulmonary congestion, red blood cell count decreased. Temozolomide dosage: 75 MG/M2; ; PO, 200 MG/M2; QD; PO. During the same period patient was treated with DIPYRONE, HYDROCHLOROTHIAZIDE, UNAT, BISOPROLOL FUMARATE. Patient was hospitalized. Patient died on 04/11/2008.Temozolomide Side Effects Report #5619275-6
Temozolomide side effect was reported by a Physician from ISRAEL on Jan 29, 2008. Male patient, 67 years of age, weighting 167.6 lb, was diagnosed with glioblastoma and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: convulsion, haemoglobin decreased, neutrophil count increased, thrombocytopenia, white blood cell count increased. Temozolomide dosage: unknown. During the same period patient was treated with CONVERTIN, GLUCOPHAGE, GLIBETIC, EPANUTIN. Patient died on 11/24/2007.
Temozolomide Side Effects Report #5811801-7
Temozolomide side effect was reported by a Physician from UNITED KINGDOM on July 08, 2008. Female patient, 52 years of age, weighting 133.2 lb, was diagnosed with glioblastoma and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: epistaxis, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Temozolomide dosage: 170 MG; PO. During the same period patient was treated with DEXAMETHASONE, LEVOMEPROMAZIN. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5825718-5
Temozolomide side effect was reported by a Physician from UNITED KINGDOM on July 11, 2008. Female patient, 52 years of age, weighting 133.2 lb, was diagnosed with glioblastoma and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: epistaxis, haemoglobin decreased, platelet count decreased. Temozolomide dosage: 170 MG; ; PO. During the same period patient was treated with DEXAMETHASON, LEVOMEPROMAZIN. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5965770-X
Temozolomide side effect was reported by a Physician from AUSTRALIA on Nov 14, 2008. Male patient, 40 years of age, was diagnosed with glioblastoma and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: cough, febrile neutropenia, haemoglobin decreased, pyrexia, red blood cell count decreased, white blood cell count decreased. Temozolomide dosage: 1500 MG; QM; IV. During the same period patient was treated with DOXORUBICIN, ACETAMINOPHEN, SALBUTAMOL, BECLOMETHASONE DIPROPIONATE, CODEINE SUL, OTRIVIN. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #6015986-1
Temozolomide side effect was reported by a Physician from AUSTRALIA on Dec 11, 2008. Male patient, 40 years of age, was diagnosed with glioblastoma and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: cough, eosinophil percentage increased, febrile neutropenia, haematocrit decreased, haemoglobin decreased, monocyte percentage increased, neutrophil percentage decreased, platelet count decreased, red blood cell count decreased. Temozolomide dosage: 1500 MG;QM;PO. During the same period patient was treated with DOXORUBICIN, PARACETAMOL, ALBUTEROL SULPHATE, BECLOMETHASONE DIPROPIONATE, CODEINE SUL, OTRIVIN. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5616652-4
Temozolomide side effect was reported by a Physician from MEXICO on Jan 28, 2008. Female patient, 67 years of age, weighting 114.6 lb, was diagnosed with colorectal cancer
and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: acidosis, asthenia, haemoglobin decreased, hepatic encephalopathy, hypotension, leukopenia, miosis, neutropenia. Temozolomide dosage: 215 MG; QD;. During the same period patient was treated with LOMOTIL. Patient was hospitalized. Patient died on 01/23/2008.Temozolomide Side Effects Report #4592890-7
Temozolomide side effect was reported by a Physician from on Feb 09, 2005. Male patient, 61 years of age, was diagnosed with astrocytoma and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: convulsion, epistaxis, fall
, haemoglobin decreased, malaise, neutropenia, pyrexia, sepsis
, thrombocytopenia. Temozolomide dosage: 215MGQDX21D* ORAL. During the same period patient was treated with TEMOZOLOMIDE CAPSULES. Patient was hospitalized. Patient died on 11/22/2004.Temozolomide Side Effects Report #5662381-0
Temozolomide side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2008. Male patient, 78 years of age, weighting 149.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: atrial fibrillation
, febrile neutropenia, haemoglobin decreased, platelet count decreased, white blood cell count decreased. Temozolomide dosage: 300 MG; QD; PO. Patient was hospitalized. Patient recovered.Temozolomide Side Effects Report #5699235-X
Temozolomide side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 07, 2008. Male patient, weighting 160.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: febrile neutropenia, haemoglobin decreased, platelet count decreased, syncope, urinary tract infection
. Temozolomide dosage: 100MG/M2 (200MG) QD PO (MISSED 3/9). During the same period patient was treated with COUMADIN, SEPTRA, AMBIEN, SENNA, COLACE, FLOMAX. Patient was hospitalized. Patient recovered.Temozolomide Side Effects Report #5920915-2
Temozolomide side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 15, 2008. Male patient, weighting 194.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: bursitis
, gait disturbance, haematocrit decreased, haemoglobin decreased, infection
, liver abscess, myelodysplastic syndrome. Temozolomide dosage: 100MG/M2 QD PO 200MG/M2 (INDUCTION) QD PO. During the same period patient was treated with VFEND, LEVAQUIN, METRONIDAZOLE, LOXITANE, PROTONIX, XANAX, MYLANTA. Patient was hospitalized. Patient recovered.Temozolomide Side Effects Report #6030534-8
Temozolomide side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 06, 2009. Female patient, weighting 117.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Temozolomide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, melaena. Temozolomide dosage: 100MG/M2 QD PO. During the same period patient was treated with ZOFRAN. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5241110-9
Temozolomide side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2007. Female patient, weighting 163.0 lb, was treated with Temozolomide. After drug was administered, patient experienced the following side effects: blood phosphorus decreased, brain oedema, depressed level of consciousness, haematocrit decreased, haemoglobin decreased, lethargy, nervous system disorder, nuclear magnetic resonance imaging brain abnormal, pulmonary embolism
. Temozolomide dosage: 3645 MG. Patient was hospitalized. Patient recovered.Temozolomide Side Effects Report #5323522-8
Temozolomide side effect was reported by a Consumer or non-health professional from UNITED STATES on May 10, 2007. Female patient, weighting 151.2 lb, was treated with Temozolomide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Temozolomide dosage: 4080 MG. During the same period patient was treated with COUMADIN, DECADRON, KEPPRA, PEPCID, ZOCOR. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5410964-5
Temozolomide side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 09, 2007. Female patient, weighting 127.4 lb, was treated with Temozolomide. After drug was administered, patient experienced the following side effects: body temperature increased, contusion, haemoglobin decreased, red blood cell count decreased, thrombocytopenia. Temozolomide dosage: unknown. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5421908-4
Temozolomide side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 21, 2007. Female patient, weighting 136.7 lb, was treated with Temozolomide. After drug was administered, patient experienced the following side effects: haemoglobin decreased, leukopenia, thrombocytopenia. Temozolomide dosage: 2760 MG. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5564333-8
Temozolomide side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 14, 2007. Male patient, weighting 206.4 lb, was treated with Temozolomide. After drug was administered, patient experienced the following side effects: anaemia, aspiration, blood fibrinogen increased, epistaxis, fibrin d dimer increased, haemoglobin decreased, haemoptysis, pulmonary embolism
, pulmonary haemorrhage. Temozolomide dosage: 4950 MG. During the same period patient was treated with BACTRIM, VALACYCLOVIR. Patient was hospitalized. Patient recovered.Temozolomide Side Effects Report #5787457-9
Temozolomide side effect was reported by a Consumer or non-health professional from UNITED STATES on June 23, 2008. Female patient, weighting 120.6 lb, was treated with Temozolomide. After drug was administered, patient experienced the following side effects: convulsion, haemoglobin decreased, leukocytosis, menorrhagia, platelet count decreased, syncope, white blood cell count decreased. Temozolomide dosage: 4750 MG. During the same period patient was treated with DECADRON, KEPPRA, PREVACID, PROCHLORPERAZINE, ZOFRAN, ZOLOFT. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5799449-4
Temozolomide side effect was reported by a Consumer or non-health professional from UNITED STATES on July 02, 2008. Female patient, weighting 120.6 lb, was treated with Temozolomide. After drug was administered, patient experienced the following side effects: convulsion, haemoglobin decreased, leukocytosis, menorrhagia, platelet count decreased, syncope, white blood cell count decreased. Temozolomide dosage: 4750 MG. During the same period patient was treated with DECADRON. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5806747-4
Temozolomide side effect was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2008. Female patient, weighting 120.6 lb, was treated with Temozolomide. After drug was administered, patient experienced the following side effects: convulsion, haemoglobin decreased, platelet count decreased, syncope, white blood cell count decreased. Temozolomide dosage: 4750 MG. During the same period patient was treated with DECADRON. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5812749-4
Temozolomide side effect was reported by a Physician from UNITED KINGDOM on July 14, 2008. Female patient, weighting 133.2 lb, was treated with Temozolomide. After drug was administered, patient experienced the following side effects: epistaxis, haemoglobin decreased, platelet count decreased. Temozolomide dosage: 3570 MG. Patient was hospitalized. Patient recovered.
Temozolomide Side Effects Report #5866966-8
Temozolomide side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2008. Male patient, weighting 249.8 lb, was treated with Temozolomide. After drug was administered, patient experienced the following side effects: conjunctival disorder, dizziness
, haemoglobin decreased, haemorrhage, headache
, neutrophil count decreased, pallor, platelet count decreased. Temozolomide dosage: 4930MG. During the same period patient was treated with PLAQUENIL, DEXAMETHASONE, NYSTATIN ORAL SOLUTION. Patient was hospitalized. Patient recovered.Temozolomide Side Effects Report #5968161-0
Temozolomide side effect was reported by a Consumer or non-health professional from CANADA on Nov 22, 2008. Female patient, weighting 140.0 lb, was treated with Temozolomide. After drug was administered, patient experienced the following side effects: asthma
, haemoglobin decreased, pneumonia aspiration, pneumonitis. Temozolomide dosage: 2500 MG. Patient was hospitalized. Patient recovered.Temozolomide Side Effects Report #4758766-7
Temozolomide side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2005. Male patient, weighting 194.0 lb, was treated with Temozolomide. After drug was administered, patient experienced the following side effects: atelectasis, back pain
, crepitations, haemoglobin decreased, lung consolidation, neutrophil count decreased, pancytopenia, platelet count decreased, pleural effusion. Temozolomide dosage: unknown. Patient was hospitalized. Patient recovered.
Temozolomide and haemoglobin decreased 